Senior Director, Market Access at Freenome

Brisbane, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

YesVisa

Biotech, In Vitro DiagnosticsIndustries

Skills

Key technologies and capabilities for this role

Market AccessReimbursementIVDCommercializationStrategyPatient CareCross-collaboration

Questions & Answers

Common questions about this position

What is the work location or remote policy for this role?

The role is hybrid with a preference for the Brisbane, California headquarters, but remote will be considered for an exceptional candidate.

What is the salary for this position?

This information is not specified in the job description.

What experience is required for the Senior Director, Market Access role?

Hands-on Market Access & Reimbursement experience for an in vitro diagnostic (IVD) during launch and early commercialization stages is required.

What is the company culture like at Freenome?

Freenome has a high-performing culture of respect and cross-collaboration that motivates the team to make every day count in their mission to outpace cancer.

What makes a strong candidate for this Market Access role?

An exceptional candidate with hands-on Market Access & Reimbursement experience for IVDs during launch may be considered for remote work and will be instrumental in crafting market access strategies.

Freenome

Biotechnology company for early cancer detection

About Freenome

Freenome focuses on improving cancer detection through advanced blood tests. The company uses a multiomics approach, analyzing various biological data types, including genomics and proteomics, to find cancer markers in blood samples. This method allows for non-invasive early detection of cancer, which is crucial for effective treatment. Freenome differentiates itself from competitors by its unique combination of data analysis techniques and its commitment to clinical trials and research collaborations. The company's goal is to enhance cancer diagnostics and make early detection accessible to healthcare providers and patients, ultimately aiming to save lives through timely intervention.

San Francisco, CaliforniaHeadquarters

2014Year Founded

$1,032.6MTotal Funding

LATE_VCCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive market-based salaries

Annual bonus opportunities

Relocation packages

Medical, dental, & vision coverage

401k

Wellness programs

Equity

PTO

Risks

Employee layoffs may affect morale and innovation efforts.

Integration of Oncimmune Ltd. could divert focus from core projects.

Competitive landscape in cancer detection may impact Freenome's market share.

Differentiation

Freenome uses a unique multiomics approach for early cancer detection.

The company focuses on non-invasive blood tests for cancer screening.

Freenome's platform designs personalized health conditions based on cell-free genome analysis.

Upsides

Recent $254 million funding boosts clinical programs and platform expansion.

Partnership with Walgreens enhances clinical trial diversity and patient recruitment.

PROACT LUNG study positions Freenome as a leader in lung cancer diagnostics.

Land your dream remote job 3x faster with AI

Try Jobo Free